3Emery TJ, Alan EH. The muscular dystrophies. Br Med J, 1998, 317(7164): 991-995.
4Olby NJ, Sharp NJ, Anderson LV. Evaluation of the dystrophia glycoprotein complex, actin dysferlin and calpain 3 in an autosomal recessive muscular dystrophia laboradory retrievers. Neuromusc ul Disord, 2001, 11 (1): 41-49.
5RowenL, Mahairas G, Hood L. Sequencing the human genome. Science,1997,278:605 ～ 607
7Roscoe O, Brady MD. Neurogene Therapy for the 21st Century. Archives of Neurology, 2000,57: 54
8Plasart E, Fontaine B. Genewith Tripleat Repeats: a new class of mutations causing neurological disease. Biomed Pharmacother, 1994,48: 191 ～ 197
9Lawp, GoodwinT, Fang QW, et al. My oblasttransferas a Platform Technology of Gene Therapy. Gene Ther MolBiology, 1998,1:1 ～ 5
10Cudkowicz ME, Mckenna-Yasek D, Sapp PE, et al. Epidemiolgy of Mutation in Superoxide Dismutase in Am yotrophic Lateral Sclerosis.Ann. Neorol, 1997,41: 210 ～ 221
